Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Monique Berlier"'
Autor:
Coimbra Sirica, John Shadid, Alison Brunier, Enricke Bouma, Monique Berlier, Rodrigue Barry, Hayatee Hasan
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background. A new group A meningococcal conjugate vaccine was developed to eliminate deadly meningitis epidemics in sub-Saharan Africa. Methods. From the outset of the project, advocacy and communication strategies were developed and adjusted as the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::112586375553ce9b57e400947c25ab12
http://europepmc.org/articles/PMC4639482
http://europepmc.org/articles/PMC4639482
Autor:
Desire Toboe, Clement Lingani, Stéphane Hugonnet, Nancy E. Messonier, Richard Mihigo, Denis Kandolo, Leonard W. Mayer, Patrick L.F. Zuber, William Perea, Mete Bonkoungou, F. Marc LaForce, Teresa Aguado, Nora Dellepiane de Rey Tolve, Carole Tevi-Benissan, Marie-Pierre Préziosi, Rodrigue Barry, Rene Sebgo, Mamoudou Harouna Djingarey, Fabien Diomandé, Dominique A. Caugant, Deo Nshimirimana, Monique Berlier, Thomas A. Clark, Sylvestre R. M. Tiendrebéogo, Ryan T. Novak, Paul A. Kristiansen
Publikováno v:
Vaccine. 30
A new Group A meningococcal (Men A) conjugate vaccine, MenAfriVac™, was prequalified by the World Health Organization (WHO) in June 2010. Because Burkina Faso has repeatedly suffered meningitis epidemics due to Group A Neisseria meningitidis specia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f015729a90ab8f0f6646334c861fd333
https://pubmed.ncbi.nlm.nih.gov/22607898
https://pubmed.ncbi.nlm.nih.gov/22607898